Supriya Lifescience also informed the exchanges that it has submitted "ground-breaking patent application" for an enhanced, ...
Pharma company Supriya Lifescience Ltd on Monday (December 9) announced it has crossed two milestones, which it says will ...
Supriya Lifesciences advanced 1.16% to Rs 783.10 after the company received approval from Brazil's health authority, ANVISA (Agcia Nacional de Vigilcia Sanitia), for Esketamine Hydrochloride.